Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effect of food on oral melphalan absorptionP A Reece, D Kotasek, R G Morris, et al.Journal of Clinical Pharmacology|September 3, 1999
Gabapentin does not affect antipyrine clearanceE Allen, L M Tsanaclis, S J Wroe, et al.Journal of Clinical Pharmacology|November 1, 1994
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansP A Reece, A J Sedman, S Rose, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinomaP A Reece, J F Bishop, I N Olver, et al.Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of L-leucine on oral melphalan kinetics in patientsP A Reece, B M Dale, R G Morris, et al.American Journal of Clinical Oncology|August 1, 1990
A phase I study of doxifluridine as a five-day stepped-dose continuous infusionI N Olver, P A Reece, J F Bishop, et al.Journal of Clinical Pharmacology|May 1, 1995
Lack of effect of tacrine administration on the anticoagulant activity of warfarinP A Reece, W R Garnett, W L Rock, et al.Therapeutic Drug Monitoring|January 1, 1989
Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patientsR G Morris, P A Reece, B M Dale, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Renal clearance and protein binding of melphalan in patients with cancerP A Reece, H S Hill, R M Green, et al.Pageof 4